Precipio Diagnostics


Precipio Diagnostics develops the ICE COLD-PCR (Ice Cold PCR) technology, claimed to preferentially enrich mutant DNA sequences in an excess of wild-type DNA through selective amplification of the mutant DNA. The result is up to a 500-fold increase in sensitivity in identifying mutations with the most precise sequence alteration detection rates available—down to .1% enabling mutation detection testing liquid biopsies. 

New Haven CT
United States
Omaha NE
United States